Corporate Information

Cambridge Biotechnology Ltd (CBT) is a wholly owned subsidiary of Proximagen Neuroscience plc. CBT operates as as an autonomous highly skilled and innovative R&D unit based in Cambridge, UK.

Any companies or investors interested in investing in CBT should contact info@cambridgebiotechnology.com for more information.